Literature DB >> 20221678

100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy.

Michael L Moritz1, Juan Carlos Ayus.   

Abstract

Hyponatremic encephalopathy is a potentially lethal condition with numerous reports of death or permanent neurological injury. The optimal treatment for hyponatremic encephalopathy remains controversial. We have introduced a unified approach to the treatment of hyponatremic encephalopathy which uses 3% NaCl (513 mEq/L) bolus therapy. Any patient with suspected hyponatremic encephalopathy should receive a 2 cc/kg bolus of 3% NaCl with a maximum of 100 cc, which could be repeated 1-2 times if symptoms persist. The approach results in a controlled and immediate rise in serum sodium with little risk of inadvertent overcorrection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221678     DOI: 10.1007/s11011-010-9173-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  57 in total

1.  Treating hyponatremia: how slow is safe? Central pontine myelinolysis despite appropriate correction of hyponatremia.

Authors:  Raza H Orakzai; Sarwar H Orakzai; Peggy B Hasley
Journal:  Eur J Intern Med       Date:  2008-03-04       Impact factor: 4.487

Review 2.  The hyponatremic patient: practical focus on therapy.

Authors:  S M Lauriat; T Berl
Journal:  J Am Soc Nephrol       Date:  1997-10       Impact factor: 10.121

3.  Central pontine myelinolysis following 'slow' correction of hyponatremia.

Authors:  S Pradhan; R Jha; M N Singh; S Gupta; R V Phadke; V Kher
Journal:  Clin Neurol Neurosurg       Date:  1995-11       Impact factor: 1.876

Review 4.  Pathogenesis and prevention of hyponatremic encephalopathy.

Authors:  J C Ayus; A I Arieff
Journal:  Endocrinol Metab Clin North Am       Date:  1993-06       Impact factor: 4.741

Review 5.  Hospital-acquired hyponatremia--why are hypotonic parenteral fluids still being used?

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Nat Clin Pract Nephrol       Date:  2007-07

6.  Randomised controlled trial of intravenous maintenance fluids.

Authors:  Michael Yung; Steve Keeley
Journal:  J Paediatr Child Health       Date:  2007-11-25       Impact factor: 1.954

7.  Symptomatic hyponatremia in rats: effect of treatment on mortality and brain lesions.

Authors:  J C Ayus; R K Krothapalli; D L Armstrong; H J Norton
Journal:  Am J Physiol       Date:  1989-07

8.  The use of isotonic fluid as maintenance therapy prevents iatrogenic hyponatremia in pediatrics: a randomized, controlled open study.

Authors:  P Alvarez Montañana; V Modesto i Alapont; A Pérez Ocón; P Ortega López; J L López Prats; J D Toledo Parreño
Journal:  Pediatr Crit Care Med       Date:  2008-11       Impact factor: 3.624

9.  [A case of alcoholic with vitamin B12 deficiency presenting central pontine and extrapontine myelinolysis on MRI].

Authors:  Akiko Nagaishi; Motohiro Yukitake; Makoto Eriguchi; Yasuo Kuroda
Journal:  Rinsho Shinkeigaku       Date:  2007-04

10.  Elevated intracranial pressure increases pulmonary vascular permeability to protein.

Authors:  M D McClellan; I M Dauber; J V Weil
Journal:  J Appl Physiol (1985)       Date:  1989-09
View more
  25 in total

1.  Ecstacy-associated hyponatremia: why are women at risk?

Authors:  Michael L Moritz; Kamyar Kalantar-Zadeh; Juan Carlos Ayus
Journal:  Nephrol Dial Transplant       Date:  2013-06-26       Impact factor: 5.992

Review 2.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

Review 3.  Impact of perioperative hyponatremia in children: A narrative review.

Authors:  Cheme Andersen; Arash Afshari
Journal:  World J Crit Care Med       Date:  2014-11-04

Review 4.  Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.

Authors:  Ewout J Hoorn; Robert Zietse
Journal:  J Am Soc Nephrol       Date:  2017-02-07       Impact factor: 10.121

5.  Syndrome of inappropriate antidiuresis and cerebral salt wasting syndrome: are they different and does it matter?

Authors:  Michael L Moritz
Journal:  Pediatr Nephrol       Date:  2012-02-23       Impact factor: 3.714

6.  Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patients.

Authors:  Haimanot Wasse; Francesca Cardarelli; Christine De Staercke; W Craig Hooper; Qi Long
Journal:  Nephrol Dial Transplant       Date:  2012-10-22       Impact factor: 5.992

7.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

Review 8.  Management of hyponatraemia in older people: old threats and new opportunities.

Authors:  Roy L Soiza; Hannah S C Talbot
Journal:  Ther Adv Drug Saf       Date:  2011-02

9.  [Hyponatremia-induced life-threatening cerebral edema after ecstasy use].

Authors:  S Baumann; T Becher; D Frambach; H Wenz; T Kirschning; M Borggrefe; S Rapp; I Akin
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-10-08       Impact factor: 0.840

10.  Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.

Authors:  Seon Ha Baek; You Hwan Jo; Soyeon Ahn; Kristianne Medina-Liabres; Yun Kyu Oh; Jung Bok Lee; Sejoong Kim
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.